Same Indication

Irbesartan vs Methotrexate

Irbesartan vs Methotrexate: Overview

This comparison examines the pharmacological differences between Irbesartan and Methotrexate.

Mechanism of Action

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Irbesartan — 11-15 hours; Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Irbesartan — C25H28N6O; Methotrexate — C20H22N8O5.

Molecular Weight: Irbesartan — 428.5320 g/mol; Methotrexate — 454.4400 g/mol.

Type: Irbesartan — Small molecule; Methotrexate — Small molecule.